Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sperm Suppression and Contraceptive Protection with Norethisterone Enantate and Testosterone Undecanoate in Healthy Men
2007-005315-26Phase 2Terminated
- Sponsor
- CONRAD
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of norethindrone enanthate and testosterone undecanoate, sponsored by CONRAD. Primary endpoints: Sperm suppression and Contraceptive protection. Started Jan 2008; status: terminated.
02
Drugs
norethindrone enanthatetestosterone undecanoate
Beyond the preview
Go deeper on 2007-005315-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005315-26.